BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:CSL Research Acceleration Initiative | Research Funding
DTSTART;VALUE=DATE:20230223
DTSTAMP:20260610T054700Z
UID:d1db4669e3c5a44e39e86bb7286aca4f660547eca0ba09044a86203f
CATEGORIES:Call for proposal
DESCRIPTION:Aim:  CSL is a leading global biotech company that develops a
 nd delivers innovative biotherapies to help people living with life threat
 ening medical conditions live full lives. CSL’s Research Acceleration In
 itiative aims to fast track discovery of innovative biotherapies through p
 artnerships between CSL and global research organizations. These partnersh
 ips provide funding and access to industry experts\nfor scientists working
  on novel biotherapeutic strategies in CSL’s therapeutic areas:\n \n\n	
 Immunology\n	Hematology\n	Respiratory\n	Cardiovascular & Metabolic\n	Trans
 plant\n	Vaccines\n\n\nAnd that are amenable to or include a CSL modality:\
 n \n\n	Antibodies\n	Recombinant Proteins\n	LV Gene Therapies\n	Cell Thera
 pies\n	Adjuvanted Vaccines\n	Cell-based vaccines\n	sa-mRNA vaccines\n\n\nF
 unding:       max. 360’000 CHF\n\nDuration:      max. 24 mont
 hs\n\nHow to Apply: Researchers who whish to apply are required to submit 
 a non-confidential\, 300-word online abstract.\n\nDeadline:      23 F
 ebruary 2023\n\nFurther information\n\n\n	Complete information can be foun
 d in the flyer (EPFL only\; login with GASPAR credentials)\n	For informati
 on on the webinar or application portal\, or for any other questions\, ple
 ase contact Alboro De Pablo Peña from the Vice Presidency for Innovation\
 n\n\n 
LOCATION:
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR